Elevated total cholesterol: its prevalence and population attributable fraction for mortality from coronary heart disease and ischaemic stroke in the Asia-Pacific region
机构:[a]The George Institute for International Health, University of Sydney,[b]School of Population Health and Clinical Practice, University of Adelaide, Australia,[c]Mount Sinai Medical Center, New York, USA,[d]Department of Public Health, University of Hong Kong,[e]Clinical Trials Research Unit, University of Auckland, New Zealand,[f]Department of Health Science, Shiga University of Medical Science, Japan,[g]Xuanwu Hospital, Capital Medical University, China首都医科大学宣武医院[h]Department of Preventive Medicine, Yonsei University College of Medicine, Korea
Background About half of the world's cases of cardiovascular disease occur in the Asia-Pacific region. The contribution of serum total cholesterol (TC) to this burden is poorly quantified. Design The most recent nationally representative data on TC distributions for countries in the region were sought. Individual participant data from 380483 adults in the Asia Pacific Cohort Studies Collaboration were used to estimate associations between TC and cardiovascular disease. Methods High TC was defined as >= 6.2 mmol/l, and nonoptimal TC as : 3.8 mmol/l. Hazard ratios for fatal coronary heart disease (CHD) and ischaernic stroke (IS) were found from Cox models. Sex-specific population attributable fractions for high TC and nonoptimal TC were estimated for each country. The former used conventional methods, based on single measures of TC and a fixed dichotomy of risk strata; the latter took account of the continuous positive association between TC and both CHD and IS and regression dilution. Results Data were available from 16 countries. Where reported, the prevalence of high TC ranged from 4 to 27%. The fraction of fatal CHD and IS attributable to high TC ranged from 0 to 14% and 0 to 15%, respectively. Although leaving the relative ranking of countries much the same, the fractions estimated for nonoptimal TC were typically at least twice as big, ranging from 0 to 47% and 0 to 35%, respectively. Conclusion Conventional methods for estimating disease burden severely underestimate the effect of TC. Cholesterollowering strategies could have a tremendous effect in reducing cardiovascular deaths in this populous region. Eur J Cardiovasc Prev Rehabil 15:397-401 (c) 2008 The European Society of Cardiology
基金:
The National Health and Medical Research Council of Australia (NHMRC; 358395) and Pfizer Inc. (unrestricted educational grant)
a Canadian Institutes of Health Research fellowship (A.M.), a NHMRC postgraduate scholarship (CMYL)
and the Korea Health 21 Project of the Ministry of Health and Welfare (A040152) (H.C.K.).
第一作者机构:[a]The George Institute for International Health, University of Sydney,[c]Mount Sinai Medical Center, New York, USA,[*]Department of Medicine, One Gustave L. Levy Place, Box 1087, New York, NY 10029-6574, USA
通讯作者:
通讯机构:[*]Department of Medicine, One Gustave L. Levy Place, Box 1087, New York, NY 10029-6574, USA
推荐引用方式(GB/T 7714):
Mark Woodward,Alexandra Martiniuk,Crystal Man Ying Lee,et al.Elevated total cholesterol: its prevalence and population attributable fraction for mortality from coronary heart disease and ischaemic stroke in the Asia-Pacific region[J].EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION.2008,15(4):397-401.doi:10.1097/HJR.0b013e3282fdc967.
APA:
Mark Woodward,Alexandra Martiniuk,Crystal Man Ying Lee,Tai Hing Lam,Stephen Vanderhoorn...&Rachel Huxley.(2008).Elevated total cholesterol: its prevalence and population attributable fraction for mortality from coronary heart disease and ischaemic stroke in the Asia-Pacific region.EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION,15,(4)
MLA:
Mark Woodward,et al."Elevated total cholesterol: its prevalence and population attributable fraction for mortality from coronary heart disease and ischaemic stroke in the Asia-Pacific region".EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION 15..4(2008):397-401